High Throughput Screening Market / HTS Market

Market Overview

High-throughput screening (HTS) is a drug discovery technique used to rapidly test a large number of chemical or biological compounds against a specific biological target. This method is extensively used in the pharmaceutical industry which utilizes robotics and automation to efficiently assess the biological or biochemical activity of many molecules in a short period. HTS uses different detection methods like fluorescence polarization (FP), fluorescence intensity distribution analysis (FIDA) and biochemical assays. With new recent technologies like miniaturization and artificial intelligence, the process has become faster which cut down the time needed for drug development. Moreover, the rise in clinical trials is leading to more drug targets for screening which is boosting the use of HTS in drug discovery. These factors are driving the growth of the high-throughput screening market. The increase in global research and development spending is a key factor driving the growth of the high-throughput screening market. Pharmaceutical and biotechnology companies are adopting open innovation models and developing new drugs for serious diseases which is further boosting market growth. The use of high-throughput screening in drug development is on the rise because it speeds up the process. Additionally, increased government funding for new technologies such as CRISPR-Cas9, RNAi and artificial intelligence is further propelling the market. Other factors such as higher healthcare spending, increased disposable income, growth in related industries and greater awareness are also positively impacting the high-throughput screening market.

High Throughput Screening Market / HTS Market Size

Report	Details
Market Size Value	USD 25.7 Billion in 2023
Market Size Value	USD 44.5 Billion by 2030
CAGR	11.6%
Forecast Period	2023-2030
Base Year	2023
Historic Data	2020

Major vendors in the global high throughput screening market / HTS market are Charles River Laboratories International Inc., Corning Incorporated, Luminex Corporation (DiaSorin), Perkinelmer Inc., Sygnature Discovery, Tecan Group Ltd., Thermo Fisher Scientific, Agilent Technologies Inc., Aurora Biomed Inc., Axxam S.p.A, Beckman Coulter Inc. (Danaher Corporation), Bio-RAD Laboratories Inc. and Others.

Growing number of HTS facilities

The market for developing new medicines for life-threatening diseases is growing. One main factor is the use of high-throughput screening (HTS) to speed up drug manufacturing. More HTS facilities are being established that is further boosting market growth. These centers provide significant benefits such as sharing knowledge among investigators, scientists and researchers. For example, the Columbia Genome Center provides top-notch molecular screening services to the Columbia University research community. Similarly, the EU-open-screen program provides open access to European companies working in chemical biology. These HTS centers aim to share valuable information about drugs, targets and processes. This open access facilitates knowledge sharing, accelerates drug development and is also expected to drive the growth of the high-throughput screening market during the forecast period.

Market Dynamics

Drivers:

• Growing number of HTS facilities
• Growth in pharmaceutical and biotechnology industries
• Increasing advancement of new molecules

Opportunities:

• Increase use of advanced high-speed screening technologies
• Increasing use in stem cell research
• Advancement in drug discovery

Increase use of advanced high-speed screening technologies

Emerging markets such as China and India are experiencing significant growth in the pharmaceutical and biotechnology industries. This growth is driven by supportive government funding and increased investments in drug discovery using high-throughput screening (HTS) technologies which provides new opportunities for HTS market players. Additionally, the use of HTS technology is expanding in fields such as personalized medicine, genomics and infectious disease research which is further driving its adoption. Governments in these developing economies are also focusing on education and training programs to develop a skilled workforce in HTS techniques. For instance, India’s Department of Biotechnology (DBT) promotes the use of HTS technology in various sectors which is including agriculture and medicine. These initiatives create a favorable environment for the adoption, development and application of HTS technologies in emerging markets.

The market for high throughput screening market / HTS market is dominated by North America.

By analysing the High throughput screening market / HTS market globally across various country like North America, Europe, Asia-Pacific, and LAMEA in which North America holds the largest market share during the forecast period. The growth is driven by technological advancements in the US. Drug discovery methods using 3D-cell cultures have become popular among companies racing to develop new drug molecules. For instance, in August 2021, Becton, Dickinson and Company introduced a new fully automated system designed for high-throughput diagnostic testing. This system uses robotics and advanced software algorithms to improve automation for infectious disease molecular testing in core and centralized laboratories across the United States. With this launch, the BD Onclarity HPV Assay with extended genotyping for the BD COR System became available to high-volume laboratories. This assay is used for processing most cervical cancer screening samples in the U.S. which is specifically for detecting persistent HPV infections.

Asia Pacific region is expected with highest compound annual growth rate (CAGR) over the forecast years. The growth is driven by increased efforts to develop new pharmaceutical molecules and the adoption of advanced technologies to enhance the quality of medicines. Japan, China and India are the major regions experiencing significant growth.

The pharmaceutical and biotechnology segment is anticipated to hold the largest market share during the forecast period

The global market is categorized by end-user into pharmaceutical and biotechnology, academia and research institutes, firms and contact research organization in which pharmaceutical and biotechnology segment held the largest market share. This growth is driven by several factors which includes the increasing development of new molecules to treat chronic conditions. The need for rapid and accurate screening of target molecules during drug discovery and development has led to the adoption of automated HTS techniques. These techniques can quickly screen large chemical and biomarker libraries generated during research. With rising pharmaceutical spending on research and development, the use of advanced technology and various business strategies, HTS methods are becoming more popular in the industry. HTS gives various benefits such as high sensitivity (detecting single molecules), high speed (automation), using minimal samples (microtiter plate assays) and the ability to detect low background signals. These advantages are driving the increased adoption of HTS in the pharmaceutical industry which is boosting market growth.

Segmentations analysis of high throughput screening market / HTS market: -

• By Technology:
  • Cell- Based Assays
  • Ultra-High-Throughput Screening
  • Label-Free Technology
  • Lab-On-A-Chip
• By Application:
  • Primary Screening
  • Toxicology
  • Target Identification
• By Products and Services:
  • Reagents
  • Kits
  • Instruments
  • Services
• By End-User:
  • Pharmaceutical and Biotechnology
  • Academia and Research Institutes
  • Firms
  • Contact Research Organisation
• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of Latin America
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • BENELUX
    • CIS & Russia
    • Nordics
    • Austria
    • Poland
    • Rest of Europe
  • Asia Pacific

• • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia & New Zealand
  • Rest of Asia Pacific

• • Middle East & Africa

• • Saudi Arabia
  • UAE
  • South Africa
  • Nigeria
  • Egypt
  • Israel
  • Turkey
  • Rest of MEA

 Recent Developments

• May 2024, Bio-Rad Laboratories, Inc. (US) introduced three new StarBright Red Dyes, StarBright Red 715, 775 and 815 which is providing more options and flexibility for conventional and full-spectrum multicolor flow cytometry panels.
• April 2024, Gordian Biotechnology launched a high-throughput in vivo screening platform designed to find treatments and more accurately predict human outcomes for age-related diseases.
• February 2024, SCIEX, a global leader in life science analytical technologies had introduced the Echo MS+ system at SLAS 2024. This system combines proprietary Acoustic Ejection Mass Spectrometry technology and Open Port Interface (OPI) sampling with the capabilities of either the SCIEX ZenoTOF 7600 or Triple Quad 6500+ systems. It provides precise qualitative and quantitative results through a broad range of high-throughput screening workflows.

   Answers to Following Key Questions:

• What will be the high throughput screening market / HTS market ’s trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers in the high throughput screening market / HTS market?
• What are the main forces behind worldwide high throughput screening market / HTS market? Which companies dominate high throughput screening market / HTS market?
• Which companies dominate high throughput screening market / HTS market? Which business possibilities, dangers, and tactics did they embrace in the market?
• What are the global insight engines industry's suppliers' opportunities and dangers in high throughput screening market / HTS market?
• What is the insight engines industry's regional sales, income, and pricing analysis? In the high throughput screening market / HTS market, who are the distributors, traders, and resellers?
• What are the main geographic areas for various trades that are anticipated to have astounding expansion over the high throughput screening market / HTS market?
• What are the main geographical areas for various industries that are anticipated to observe astounding expansion for high throughput screening market / HTS market?
• What are the dominant revenue-generating regions for high throughput screening market / HTS market, as well as regional growth trends?
• By the end of the forecast period, what will the market size and growth rate be?
• What are the main high throughput screening market / HTS market trends that are influencing the market's expansion?
• Which key product categories dominate high throughput screening market / HTS market? What is high throughput screening market / HTS market ’s main applications?
• In the coming years, which high throughput screening market / HTS market technology will dominate the market?